Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/03/1997 | WO1997023501A1 Therapeutic compositions |
07/03/1997 | WO1997023500A1 Endothelial cell proliferation inhibitor and method of use |
07/03/1997 | WO1997023499A1 Prodrugs of thrombin inhibitors |
07/03/1997 | WO1997023256A1 Localized intravascular delivery of growth factors for promotion of angiogenesis |
07/03/1997 | WO1997023244A1 Use of antisene oligodeoxynucleotides to produce truncated proteins |
07/03/1997 | WO1997023239A1 Dry compositions |
07/03/1997 | WO1997023237A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
07/03/1997 | WO1997023235A1 Anti-lps factor from horseshoe crabs and methods of use |
07/03/1997 | WO1997018238A3 Crf analogs |
07/03/1997 | WO1997018232A3 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae |
07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
07/03/1997 | DE19548367A1 Immunologisch wirksame Mistelextraktzubereitungen Immunologically effective mistletoe extract preparations |
07/03/1997 | CA2241129A1 Therapeutic compositions |
07/03/1997 | CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
07/03/1997 | CA2240941A1 Galactopyranosides and their use |
07/03/1997 | CA2240834A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
07/03/1997 | CA2239711A1 Compounds with growth hormone releasing properties |
07/03/1997 | CA2239704A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof |
07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
07/03/1997 | CA2239303A1 Globins containing binding domains |
07/03/1997 | CA2238737A1 Prodrugs of thrombin inhibitors |
07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
07/03/1997 | CA2213512A1 Method for producing bioactive fusion protein |
07/02/1997 | EP0781847A1 Humanized monoclonal antibody |
07/02/1997 | EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production |
07/02/1997 | EP0781844A1 Gene participating in apoptosis |
07/02/1997 | EP0781779A2 Nonantigenic stabilizer and physiologically active substance |
07/02/1997 | EP0781778A1 Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
07/02/1997 | EP0781560A1 Use of immunoglobulin preparations for the production of a drug for oral administration for treatment and prophylaxis of chronic pain conditions |
07/02/1997 | EP0781558A2 Pharmaceutical use of heparin cofactor II |
07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
07/02/1997 | EP0781436A1 System and method of automatically generating chemical compounds with desired properties |
07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
07/02/1997 | EP0781338A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
07/02/1997 | EP0781337A1 Humanised antibody to integrin chain beta-1 |
07/02/1997 | EP0781336A1 A human map kinase homolog |
07/02/1997 | EP0781335A1 Cloning and characterizing of genes associated with long-term memory |
07/02/1997 | EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
07/02/1997 | EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
07/02/1997 | EP0781331A1 Improvements in or relating to binding proteins for recognition of dna |
07/02/1997 | EP0781326A1 The irs family of genes |
07/02/1997 | EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
07/02/1997 | EP0781295A1 Asp b1 insulin analogs |
07/02/1997 | EP0781294A1 Metal-containing ribonucleotide polypeptides |
07/02/1997 | EP0781143A1 Method of blocking the sec receptor |
07/02/1997 | EP0781142A1 Compositions and methods for delivery of polypeptides |
07/02/1997 | EP0781141A1 Aza cyclohexapeptide compounds |
07/02/1997 | EP0781140A1 Corticotropin release inhibiting factor and methods of using same |
07/02/1997 | EP0781139A1 Intracellular delivery of chemical agents to a specific cell type |
07/02/1997 | EP0781124A1 Active agent transport systems |
07/02/1997 | EP0781095A1 Cells bearing cd4 decoy receptors and related molecules and methods |
07/02/1997 | EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a |
07/02/1997 | EP0629347B1 Antibacterial agent and treatment of article therewith |
07/02/1997 | EP0627000A4 Mammalian expression systems for hcv proteins. |
07/02/1997 | EP0621871B1 A human kunitz-type protease inhibitor variant |
07/02/1997 | EP0592692B1 Fed batch process for protein secreting cells |
07/02/1997 | EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
07/02/1997 | CN1153529A Hepatitis G virus and molecular cloning thereof |
07/02/1997 | CN1153528A Pantropic neurotrophic factors |
07/02/1997 | CN1153477A Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof |
07/02/1997 | CN1153062A Human urinary trypsin inhibitor preparation and method for production thereof |
07/01/1997 | USH1662 Chemically modified lymphokine and production thereof |
07/01/1997 | US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders |
07/01/1997 | US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
07/01/1997 | US5644046 Cloning of a gene encoding for the growth hormone releasing hormone receptor |
07/01/1997 | US5644045 X-linked adrenoleukodystrophy gene and corresponding protein |
07/01/1997 | US5644036 Purified immunoglobulin |
07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
07/01/1997 | US5644034 Tumour necrosis factor binding ligands |
07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
07/01/1997 | US5644031 Delta-like gene expressed in neuroendocrine tumors |
07/01/1997 | US5644030 Gene and method for production of an IgA binding protein |
07/01/1997 | US5644026 Antitumor agent polypeptides |
07/01/1997 | US5644025 Tetrapeptides deriving from dalbaheptide antibiotics |
07/01/1997 | US5644024 Tetrahydronaphthalene derivatives |
07/01/1997 | US5643957 Compounds and compositions for delivering active agents |
07/01/1997 | US5643949 Cosmetic composition for hair and skin disorders in humans |
07/01/1997 | US5643924 Retroviral protease inhibitors |
07/01/1997 | US5643904 Treating pain, ulcers, collitis, anxiety and panic disorder |
07/01/1997 | US5643891 Treatment of viral infections |
07/01/1997 | US5643890 Anticarcinogenic agents |
07/01/1997 | US5643881 Protein having anti-HIV activity and method for obtaining it |
07/01/1997 | US5643880 Casein isolated from milk and joining to oropharyngeal cells |
07/01/1997 | US5643879 Oligopeptide enzyme inhibitors as hypotensive agents |
07/01/1997 | US5643878 Treatment of retroviral diseases like aids |
07/01/1997 | US5643877 Compounds comprising gonadotropin releasing hormone (GnRH) and methods for controlling reproduction in fish |
07/01/1997 | US5643876 Biologically active synthetic magainin peptides |
07/01/1997 | US5643875 Proteins and endotoxins |
07/01/1997 | US5643873 Antiinflammatory |
07/01/1997 | US5643872 Antiagglomerants for platelets, anticoagulants |
07/01/1997 | US5643871 Antitumor antibiotics |
07/01/1997 | US5643870 Topical asthma treatment |
07/01/1997 | US5643869 Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
07/01/1997 | US5643868 Method of treating or preventing type 1 diabetes by oral administration of insulin |
07/01/1997 | US5643867 Method for treating catabolic conditions |
07/01/1997 | US5643786 Method for isolating dendritic cells |
07/01/1997 | US5643785 Polynucleotides encoding AMPA-binding human GluR4 receptors |
07/01/1997 | US5643781 DNA encoding protocadherin-42 |